Dr. Jun Chung, MD

Dr. Chung practices at Jun Chung MD (정준내과) in Los Angeles, California.

Dr. Chung's NPI, 1205190659, was assigned on June 30, 2012. Dr. Chung graduated from Indiana University School Of Medicine in 2012. Dr. Chung holds California license A135724.

Dr. Chung's primary practice is Jun Chung MD (정준내과), at 3000 W Olympic Blvd Ste 203, Los Angeles, CA 90006-2588. The practice phone is (812) 361-8328.

Dr. Chung's primary practice is Jun Chung MD (정준내과) in Los Angeles, California. The medical group on file is Nanoom Medical Group. Dmand AI also links Dr. Chung to 2 more home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chung practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chung's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chung is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chung's licenses on file in 3 states: California, Missouri and South Carolina.

Dmand AI lists acid reflux, aneurysm, anxiety, aortic atherosclerois, arthritis, asthma, atrial fibrillation and flutter and bronchitis among the conditions Dr. Chung treats.

CMS data shows 4,725 Medicare services from Dr. Chung across 19 procedure codes in 2024, for 158 Medicare patients. Medicare paid $228,859 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Dr. Chung in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 78% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chung's median patient age at 66, with 57% women.

In 2024, Dr. Chung wrote 10,327 Medicare Part D claims for 478 patients. 75% of them were for generic drugs. CMS names the drug for 9,702 of them, across 154 drugs with 11 or more claims each, at $1,904,758 in total drug cost. In 2023, CMS named 2,544 claims across 76 drugs.

Dr. Chung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chung as offering telehealth.

Dmand AI links 39 papers to Dr. Chung, published from 2010 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Breast Neoplasms, Cell Line, Tumor and Cell Movement. Dr. Chung has published most often in Cureus. Dr. Chung's most frequent co-authors are Jun Ho Chung, MD, Olumide A. Danisa, MD and Wayne K. Cheng, MD.

CMS Open Payments shows 335 general payments to Dr. Chung from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. AstraZeneca Pharmaceuticals LP paid the most, $9,820.

Dr. Chung graduated from Indiana University School Of Medicine in 2012.

Dr. Chung is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.